Jacob Rhame undergoes season-ending ulnar nerve surgery

The Mets announced today that relief pitcher Jacob Rhame underwent ulnar nerve transposition surgery today, which puts an end to his 2019 season. He hasn’t pitched all that much this year, but in 19.2 innings with Syracuse, he had a 5.49 ERA and 4.63 FIP.

Rhame’s major league work this year was a mixed bag. He managed a 4.26 ERA in his 6.1 innings of work despite walking a staggering 12.79 batters per nine innings. Combined with a strikeout rate of 7.11 per nine, his relative success did not come off as being sustainable.

Rhame was oriiginally acquired by the Mets when they traded away Curtis Granderson at the deadline in 2017. Like most of his peers who were acquired at the time, he has not panned out thus far at the major league level. In 47.2 innings with the Mets over parts of the last three seasons, Rhame has a 6.23 ERA and 6.06 FIP.